Catalyst Pharmaceuticals, Inc.

CPRXDelisted Jul 15, 2026

Industry: Pharmaceutical Preparations
SEC CIK: 0001369568

SEC filings (opens in a new tab)

Catalyst Pharmaceuticals, Inc. was delisted on Jul 15, 2026; its insiders filed their last Form 4 on Jul 17, 2026; 396 institutions reported holding it in 13F filings for Q2 2026, worth $3.39B in total; Soros Fund Management was the only superinvestor holding it.

Q2 2021 vs. Q1 2021

How the institutions holding Catalyst Pharmaceuticals, Inc. changed between Q1 2021 and Q2 2021.

All holders in Q2 2021 All holders in Q1 2021

13F holders of CPRX: Q1 2021 compared with Q2 2021
Measure	Q1 2021	Of which not filed for Q2 2021	Q2 2021	Change
Holders	133	1	139	+7
Shares	67.7M	18.1K	65.5M	−2.19M (−3.2%)
Value	$312.0M	$84.0K	$376.6M	+$64.7M (+20.7%)

1 institution that held it in Q1 2021 haven't filed for Q2 2021 yet. Not filing isn't selling, so the changes leave them out.

New holders (23)

Institutions that held Catalyst Pharmaceuticals, Inc. at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to CPRX in Q2 2021
Institution	Shares	Value	% of portfolio
Los Angeles Capital Management LLC	173,785	$999.0K	0.00%
Janus Henderson Group PLC	170,063	$978.0K	0.00%
Hussman Strategic Advisors, Inc.	124,000	$713.0K	0.15%
Alberta Investment Management Corp	118,800	$683.0K	0.01%
Group One Trading, L.P.	105,248	$605.0K	0.01%
Allianz Asset Management GmbH	94,966	$546.0K	0.00%
Summit Global Investments	57,500	$331.0K	0.02%
Origin Asset Management LLP	54,618	$314.0K	0.04%
Qube Research & Technologies Ltd	44,264	$255.0K	0.00%
Campbell & CO Investment Adviser LLC	42,900	$247.0K	0.11%
Maverick Capital LtdSuperinvestorMaverick Capital	35,869	$206.0K	0.00%
Ergoteles LLC	33,700	$194.0K	0.00%
Belvedere Trading LLC	28,488	$160.0K	0.07%
ExodusPoint Capital Management, LP	26,318	$151.0K	0.00%
Sawgrass Asset Management LLC	23,190	$133.0K	0.01%
HighTower Advisors, LLC	22,751	$132.0K	0.00%
Jane Street Group, LLC	21,012	$121.0K	0.00%
Altshuler Shaham Ltd	19,060	$110.0K	0.00%
XTX Topco Ltd	19,216	$110.0K	0.04%
IFG Advisory, LLC	13,723	$78.0K	0.01%
Virtu Financial LLC	13,295	$76.0K	0.01%
Leonteq Securities AG	4,000	$23.0K	0.00%
First Manhattan Co	250	$1.00K	0.00%

Sold out (16)

Institutions that held Catalyst Pharmaceuticals, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.

Institutions that sold out of CPRX in Q2 2021
Institution	Shares, Q1 2021	Value, Q1 2021
Schroder Investment Management Group	767,041	$3.54M
California Public Employees Retirement System	197,300	$910.0K
ClariVest Asset Management LLC	137,400	$634.0K
Marshall Wace, LLP	103,332	$476.0K
QS Investors, LLC	86,400	$399.0K
Squarepoint Ops LLC	75,781	$349.0K
Lazard Asset Management LLC	21,583	$99.0K
Wolverine Trading, LLC	15,622	$68.0K
SEI Investments Co	18,905	$63.0K
Quantitative Systematic Strategies LLC	13,104	$60.0K
Ameriprise Financial Inc	10,955	$50.0K
Pacer Advisors, Inc.	10,206	$47.0K
Steward Partners Investment Advisory, LLC	2,600	$12.0K
Sowell Financial Services LLC	1,784	$8.00K
New York State Teachers Retirement System	1,100	$5.00K
Eudaimonia Partners, LLC	1,000	$5.00K

Not filed for Q2 2021 yet (1)

Institutions that held Catalyst Pharmaceuticals, Inc. at the end of Q1 2021 and haven't filed a 13F for Q2 2021. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding CPRX in Q1 2021 that haven't filed for Q2 2021
Institution	Shares, Q1 2021	Value, Q1 2021
E Fund Management Co., Ltd.	18,138	$84.0K